Author:
Bavadharani M , A. Reyana , Dr Uma S
Published in
Journal of Science Technology and Research
( Volume , Issue )
Abstract
Delicate Tissue Tumors (STT) are a type of sarcoma found in tissues that interface, backing, and encompass body structures. Due to their shallow recurrence in the body and their extraordinary variety, they seem, by all accounts, to be heterogeneous when seen through Magnetic Resonance Imaging (MRI). They are effortlessly mistaken for different infections, for example, fibro adenoma mammae, lymphadenopathy, and struma nodosa, and these indicative blunders have an extensive unfavorable impact on the clinical treatment cycle of patients. Analysts have proposed a few AI models to characterize cancers, however none have sufficiently tended to this misdiagnosis issue. Likewise, comparative investigations that have proposed models for assessment of such cancers generally don't think about the heterogeneity and the size of the information. Thusly, we propose an AI based approach which joins another strategy of pre handling the information for highlights change, resampling methods to dispense with the predisposition and the deviation of precariousness and performing classifier tests in light of the and Deep learning Algorithm as Artificial brain organization.
Keywords
Machine Learning (ML), Magnetic Resonance Imaging (MRI)., Delicate Tissue Tumors (STT)
References
Data not available

ABSTRACT:

Soft Tissue Tumors (STT) are rare sarcomas that affect muscles, fat, nerves, and connective tissues. Due to their low frequency and heterogeneous appearance on MRI scans, doctors often misidentify them as other conditions like fibroadenoma or lymphadenopathy. These diagnostic errors negatively affect patient treatment outcomes. Although researchers have developed AI models for tumor classification, most fail to address data imbalance and image inconsistency. This study proposes a Machine Learning Improved Advanced approach that uses refined preprocessing, resampling methods, and deep learning algorithms. These methods reduce data bias and enhance classifier accuracy. Specifically, our approach uses artificial neural networks to support early detection and accurate diagnosis of STT. The system processes MRI images, detects texture and structural patterns, and predicts tumor type. This AI-driven solution offers improved performance over traditional diagnostic tools, helping doctors make faster, more reliable treatment decisions and improving patient care in oncology.

INTRODUCTION:

Soft tissues include muscles, fat, vessels, and nerves that support body organs. Tumors in these tissues, called Soft Tissue Sarcomas (STS), can grow anywhere in the body. Diagnosing these cancers is difficult due to image noise, the tumor variation, and misleading visual patterns. Although MRI is widely used, its inconsistencies and lack of clarity hinder accurate interpretation. Humans have limited ability to detect subtle MRI texture changes, making diagnosis challenging. To solve this, researchers now apply Machine Learning Improved Advanced techniques. These systems process MRI data to detect and classify tumors more effectively. Our proposed AI model uses textural features, shape data, and deep learning to enhance diagnosis. It overcomes issues like data imbalance and heterogeneity, which typically reduce model accuracy. By automating tumor recognition, the system helps doctors identify cancers early and choose better treatments. This technology has become an essential part in modern medicine and supports precision oncology.

MACHINE LEARNING IMPROVED ADVANCED DIAGNOSIS OF SOFT TISSUES TUMORS

DOWNLOAD

INDEXED IN